Relestal
Formulation
Each mL syrup (oral drops) contains:
Dicycloverine hydrochloride 5 mg

 

 

Each 5 mL (1 teaspoonful) syrup contains:
Dicycloverine hydrochloride 10 mg

 

 

Dicycloverine HCl

Relestal®

Prescription Drug

Indication

For the treatment of functional disturbances of gastrointestinal motility such as irritable bowel syndrome and renal and biliary colic. As with other antispasmodics, Dicycloverine has limited efficacy in the treatment of these disorders and should be used only if other measures (e.g. diet) have been of little or no benefit.

Dicycloverine has been used alone or in combination with phenobarbital in the treatment of infant colic and acute enterocolitis but lacks substantial evidence of efficacy in these conditions. Infant colic is considered a benign and self-limiting condition.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Information Leaflet.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.